Cargando…
Glibenclamide Enhances the Therapeutic Benefits of Early Hypothermia after Severe Stroke in Rats
Glibenclamide (GBC) is an antidiabetic drug that is in a class of medications known as sulfonylureas, which play critical roles in attenuating brain edema and reducing mortality in ischemic stroke patients. Therapeutic hypothermia (TH) is another robust neuroprotectant that prevents brain swelling a...
Autores principales: | Zhu, Shuzhen, Gao, Xiaoya, Huang, Kaibin, Gu, Yong, Hu, Yafang, Wu, Yongming, Ji, Zhong, Wang, Qing, Pan, Suyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065285/ https://www.ncbi.nlm.nih.gov/pubmed/30090656 http://dx.doi.org/10.14336/AD.2017.0927 |
Ejemplares similares
-
Glibenclamide Is Comparable to Target Temperature Management in Improving Survival and Neurological Outcome After Asphyxial Cardiac Arrest in Rats
por: Huang, Kaibin, et al.
Publicado: (2016) -
Neuropsychological Deficits Chronically Developed after Focal Ischemic Stroke and Beneficial Effects of Pharmacological Hypothermia in the Mouse
por: Zhong, Weiwei, et al.
Publicado: (2020) -
Synergistically Induced Hypothermia and Enhanced Neuroprotection by Pharmacological and Physical Approaches in Stroke
por: Zhang, Jun, et al.
Publicado: (2018) -
Mild Therapeutic Hypothermia Protects the Brain from Ischemia/Reperfusion Injury through Upregulation of iASPP
por: Liu, Xiangrong, et al.
Publicado: (2018) -
Mitochondrial Creatine Kinase is Decreased in the Serum of Idiopathic Parkinson’s Disease Patients
por: Xu, Jinghui, et al.
Publicado: (2019)